Pharmaids Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 1.46 | 1.14 | 1.21 |
Operating Expense | 5.99 | 2.81 | 2.94 |
Net Profit | -4.36 | -3.06 | -1.59 |
Net Profit Margin | -298.63 | -268.42 | -131.40 |
Earning Per Share | -1.24 | -0.86 | -0.45 |
EBIDTA | -3.20 | -0.96 | -1.47 |
Effective Tax Rate | TBA | TBA | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 1.46 |
Operating Expense | 5.99 |
Net Profit | -4.36 |
Net Profit Margin | -298.63 |
Earning Per Share | -1.24 |
EBIDTA | -3.20 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 2.34 | 0.03 | TBA |
Operating Expenses Annual | 9.60 | 6.40 | 9.89 |
Operating Profit Annual | -6.24 | -5.58 | -9.89 |
Interest Annual | 2.15 | 0.33 | TBA |
Depreciation | 0.20 | 0.18 | 0.02 |
Net Profit Annual | -7.28 | -4.95 | -7.56 |
Tax Annual | -1.31 | -1.14 | -2.35 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 2.34 |
Operating Expenses Annual | 9.60 |
Operating Profit Annual | -6.24 |
Interest Annual | 2.15 |
Depreciation | 0.20 |
Net Profit Annual | -7.28 |
Tax Annual | -1.31 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 2.46 | 12.75 | 0.41 |
Cash Flow from Operations | -7.72 | -3.44 | -4.02 |
Cash Flow from Investing | -18.90 | -72.51 | -4.95 |
Cash Flow from Financing | 24.64 | 65.66 | 21.31 |
Cash Flow at the End | 0.47 | 2.46 | 12.75 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 2.46 |
Cash Flow from Operations | -7.72 |
Cash Flow from Investing | -18.90 |
Cash Flow from Financing | 24.64 |
Cash Flow at the End | 0.47 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | -266.67 | -18,600 | TBA |
PBIT Margin (%) | -275.21 | -19,200 | TBA |
PBT Margin (%) | -147.00 | 38,966.67 | TBA |
Net PROFIT Margin (%) | -311.11 | -16,500 | TBA |
Return On Networth / Equity (%) | TBA | TBA | TBA |
Return On Networth /Employed (%) | TBA | TBA | TBA |
Return On Assets (%) | -6.22 | TBA | TBA |
Total Debt / Equity (X) | 0.39 | 0.14 | TBA |
Asset Turnover Ratio (%) | 0.02 | TBA | TBA |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | -266.67 |
PBIT Margin (%) | -275.21 |
PBT Margin (%) | -147.00 |
Net PROFIT Margin (%) | -311.11 |
Return On Networth / Equity (%) | TBA |
Return On Networth /Employed (%) | TBA |
Return On Assets (%) | -6.22 |
Total Debt / Equity (X) | 0.39 |
Asset Turnover Ratio (%) | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 24.18 | 16.55 | 0.11 |
Total Current Assets Annual | 12.68 | 4.76 | 18.28 |
Non Current Assets Annual | 106.01 | 80.24 | 6.27 |
Total Shareholders Funds Annual | 63.79 | 71.06 | 22.43 |
Total Assets Annual | 118.69 | 85.00 | 24.55 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 24.18 |
Total Current Assets Annual | 12.68 |
Non Current Assets Annual | 106.01 |
Total Shareholders Funds Annual | 63.79 |
Total Assets Annual | 118.69 |
EPS (INR)
Expected
0.00
Reported
-1.41
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%